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4-Hydroxyacetophenone monooxygenase from
Pseudomonas fluorescens ACB
A novel flavoprotein catalyzing Baeyer±Villiger oxidation of aromatic compounds
Nanne M. Kamerbeek1, MarieÈ lle J. H. Moonen2, Jos G. M. van der Ven1,*, Willem J. H. van Berkel2,
Marco W. Fraaije1 and Dick B. Janssen1
1Laboratory of Biochemistry, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, the Netherlands;
2Laboratory of Biochemistry, Department of Agrotechnology and Food Sciences, Wageningen University, the Netherlands
A novel flavoprotein that catalyses the NADPH-dependent
oxidation of 4-hydroxyacetophenone to 4-hydroxyphenyl
acetate, was purified to homogeneity from Pseudomonas
fluorescens ACB. Characterization of the purified enzyme
showed that 4-hydroxyacetophenone monooxygenase
(HAPMO) is a homodimer of < 140 kDa with each subunit
containing a noncovalently bound FAD molecule. HAPMO
displays a tight coupling between NADPH oxidation and
substrate oxygenation. Besides 4-hydroxyacetophenone a
wide range of other acetophenones are readily converted
via a Baeyer±Villiger rearrangement reaction into the
corresponding phenyl acetates. The P. fluorescens HAPMO
gene (hapE) was characterized. It encoded a 640 amino-
acid protein with a deduced mass of 71 884 Da. Except
for an N-terminal extension of < 135 residues, the sequence
of HAPMO shares significant similarity with two known
types of Baeyer±Villiger monooxygenases: cyclohexanone
monooxygenase (27±33% sequence identity) and steroid
monooxygenase (33% sequence identity). The HAPMO
sequence contains several sequence motifs indicative for
the presence of two Rossman fold domains involved in FAD
and NADPH binding. The functional role of a recently
identified flavoprotein sequence motif (ATG) was explored
by site-directed mutagenesis. Replacement of the strictly
conserved glycine (G490) resulted in a dramatic effect on
catalysis. From a kinetic analysis of the G490A mutant it is
concluded that the observed sequence motif serves a struc-
tural function which is of importance for NADPH binding.
Keywords: aromatic ketones; Baeyer±Villiger monooxy-
genase; flavoprotein; 4-hydroxyacetophenone monooxy-
genase; mutagenesis.
The aerobic degradation of aromatic compounds by soil
bacteria depends on the activity of oxygenases [1]. So far
two classes of flavoprotein hydroxylases have been shown
to act as aromatic monooxygenases: the single component
aromatic hydroxylases [2] and two-component hydroxy-
lases [3,4]. The single component aromatic hydroxylases
share a typical dinucleotide binding fold for complexation
of the FAD cofactor while lacking a NAD(P) binding fold
[5]. An extensively studied member of this widespread
class of flavoenzymes is p-hydroxybenzoate hydroxylase
[6,7]. Mechanistic studies have shown that the monooxy-
genation reactions catalysed by single component aromatic
hydroxylases are preceded by NAD(P)H-mediated flavin
reduction. The reduced flavin then reacts with dioxygen to
form a reactive electrophilic hydroperoxyflavin intermedi-
ate which is able to introduce a hydroxyl group into an
activated aromatic ring [8]. The two-component hydroxy-
lases typically consist of a relatively small flavin reductase
which generates reduced flavin at the expense of NAD(P)H.
After intermolecular transfer, the reduced flavin is used by
the large oxygenating component to catalyse substrate
hydroxylation [9,10]. Although the genes of several of these
two-component hydroxylases have been identified, mech-
anistic data on this type of monooxygenases are scarce.
Except for the above-mentioned monooxygenation reac-
tions another route of flavoenzyme-mediated oxygenation
of aromatic compounds has been suggested in the literature.
For several bacteria it was found that their ability to
degrade aromatic compounds depends on an enzyme-
mediated Baeyer±Villiger reaction in which an oxygen
atom is inserted between the aromatic ring and a ketone
side chain (Scheme 1). These Baeyer±Villiger reactions
have been detected during studies on the microbial degra-
dation of several ring-substituted acetophenones [11±13]
and 4-ethylphenol [14,15]. Recently, a Baeyer±Villiger
monooxygenase from Pseudomonas putida JD1, involved
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in 4-ethylphenol metabolism, was purified and partially
characterized [16]. However, enzymes involved in these
atypical metabolic pathways have never been cloned.
All Baeyer±Villiger monooxygenases identified so far
were shown to be flavoproteins [17]. As for the single
component hydroxylases, also for these enzymes a per-
oxygenated flavin has been proposed as the oxygenating
species [18]. However, in the Baeyer±Villiger reaction this
reactive flavin intermediate is supposed to act as a
nucleophile indicating that in these monooxygenases a
peroxyflavin anion is involved in substrate attack [19,20].
Pseudomonas fluorescens ACB is able to use 4-hydro-
xyacetophenone as sole carbon and energy source [13].
Since it was suggested that the microbial degradation of this
phenolic compound is initiated by a Baeyer±Villiger
reaction (Scheme 1), we started a study to identify this
atypical aromatic monooxygenase. We report here on the
purification, gene cloning, sequence analysis and charac-
terization of 4-hydroxyacetophenone monooxygenase
(HAPMO). It is shown that the enzyme is a FAD-dependent
Baeyer±Villiger monooxygenase that is active with a wide
range of aromatic ketones. A preliminary report on the
purification of HAPMO from P. fluorescens ACB has been
presented elsewhere [21].
M A T E R I A L S A N D M E T H O D S
Chemicals
Restriction enzymes, 7-deaza-dGTP, and isopropyl thio-b-
d-galactoside were obtained from Roche. NADH, NADPH,
dithiothreitol, glucose oxidase (grade II) and catalase were
from Boehringer. Tris, FAD, FMN and riboflavin were from
Sigma. Q-Sepharose Fast Flow, phenyl-Sepharose Fast
Flow, Superdex 200 Prep Grade, Superdex PG200 HR
10/30 and molecular weight markers were from Pharmacia.
Bio-Gel P-6DG and Macro-Prep Ceramic Hydroxyapatite
(Type I, particle size 20 mm) were from Bio-Rad. Acryl-
amide, bisacrylamide and Coomassie brilliant blue G250
were from Serva. Aromatic ketones were purchased from
Acros, Aldrich, Fluorochem and Lancaster. Stock ketone
solutions were prepared in dimethyl formamide. H182 O (97
atom % 18O) was from Campro (Elst, the Netherlands). All
other chemicals were of commercially available analytical
grade.
Bacterial strains and culture conditions
P. fluorescens ACB was kindly provided by D. D. Focht
(University of California, Riverside, USA). P. fluorescens
ACB was isolated from activated sewage sludge by
enrichment and serial transfer with 4-hydroxyacetophenone
as growth substrate [13] and grown in 0.8% Nutrient Broth
(Difco) at 30 8C or in minimal medium based on KroÈckel
and Focht [22], containing per litre demineralized water:
3.5 g Na2HPO4, 1.4 g KH2PO4, 0.5 g (NH4)2SO4, 0.2 g
MgSO4.7H2O, 10 mg yeast extract and 5 mL of a trace
elements solution. The trace elements solution contained
per litre: 780 mg Ca(NO3)2´4H2O, 200 mg FeSO4´7H2O,
10 mg ZnSO4´7H2O, 10 mg H3BO3, 11.8 mg
CoSO4´7H2O, 4 mg MnSO4´1H2O, 3 mg Na2MoO4´2H2O,
2 mg NiCl2´6H2O, 10 mg CuSO4´5H2O and 2 mg
Na2WO4´2H2O (adjusted to pH 2 with H2SO4). The final
pH of the medium was 7.0. Cells were grown on 10 mm
4-hydroxyacetophenone at 30 8C in 2 L Erlenmeyer flasks
agitated at 270 r.p.m. on an orbital shaker to provide
suitable aeration. Large-scale growth, with 4-hydroxy-
acetophenone as the sole carbon and energy source, was
performed batchwise in a 200-L fermentor (Bioengineering
AG) at 30 8C. During growth, the medium was stirred at
150 r.p.m. and flushed with 30 L air´min21 and the pH was
kept constant at pH 7.0 with NaOH. The fermentor was
inoculated with 2 L cell culture, and growth was induced by
the addition of 5 mm 4-hydroxyacetophenone, followed by
two portions of 10 mm 4-hydroxyacetophenone at 8-h
intervals. The cells were harvested after 24 h and the cell
paste (< 235 g wet weight) was frozen and stored at
280 8C. Under these conditions, no significant loss of
HAPMO activity occurred over a period of 6 months.
Escherichia coli strains HB101, TOP10F 0 and BL21(DE3)
pLysS were grown in Luria±Bertani medium supplemented
with the appropriate antibiotic at 20, 30 or 37 8C.
Enzyme purification from P. fluorescens ACB
HAPMO was purified from P. fluorescens ACB to apparent
homogeneity in two chromatographic steps. All purification
steps were performed at 4 8C. Cells (200 g wet weight)
were suspended in 21 mm potassium phosphate pH 7.1, and
disrupted through a precooled Manton Gaulin press. The
clarified cell extract was treated with 0.25% (w/v)
protamine sulfate and the supernatant obtained after
centrifugation was loaded onto a Q-Sepharose column
(5  25 cm), equilibrated in 21 mm potassium phosphate
pH 7.1. After washing with 2 vol. starting buffer, the
HAPMO activity was eluted with a linear gradient of
0±0.7 m KCl in starting buffer. Active fractions were
concentrated by ultrafiltration (Amicon YM-30 membrane)
and diluted with 3 vol. 10 mm potassium phosphate,
pH 7.1. The enzyme solution was then adjusted to 1 m
ammonium sulfate and loaded onto a phenyl Sepharose
column (2.5  40 cm), equilibrated in 50 mm potassium
phosphate pH 7.1, containing 1 m ammonium sulfate. After
washing with starting buffer, the HAPMO activity was
eluted with a linear descending gradient of 1±0 m ammonium
sulfate in 50 mm potassium phosphate, pH 7.1. Active
fractions were concentrated by ultrafiltration, dialysed in
50 mm potassium phosphate, pH 7.1, and stored at 280 8C.
The 4-hydroxyphenyl acetate hydrolase was purified
from P. fluorescens ACB in three chromatographic steps.
Cell extract was loaded on a DEAE±Sepharose column
(6  2.5 cm) equilibrated in 21 mm phosphate pH 7.1.
Esterase activity was eluted with a linear gradient of
0±0.7 m KCl in starting buffer. Active fractions were
pooled, dialysed against 1 mm phosphate pH 7.1, and
loaded on a hydroxyapatite column (7  3 cm) equili-
brated in 1 mm phosphate pH 7.1. Esterase activity was
eluted with a linear gradient of 1±100 mm phosphate
Scheme 1.
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pH 7.1. Active fractions were pooled, concentrated and
loaded on a Sephacryl S-200 column (34  1 cm) running
in 21 mm potassium phosphate, pH 7.1. The fractions with
the highest esterase activity were pooled, resulting in an
enzyme preparation which was more than 75% pure. For
N-terminal sequencing, the esterase was isolated from a
SDS-containing polyacrylamide gel.
Preparation of the genomic library
All DNA isolation and cloning procedures were carried out
essentially as described by Sambrook et al. [23]. A genomic
library of P. fluorescens ACB was constructed in the
cosmid vector pLAFR3 according to the strategy described
by Staskawicz et al. [24]. CsCl gradient centrifugation was
used to purify pLAFR3 isolated from E. coli HB101.
Constructed vector arms and inserts were ligated and
subsequently packaged in vitro with a DNA-packaging kit
(Boehringer). E. coli HB101 cells were infected with the
packaging mix and transducts were selected on Luria±
Bertani plates supplemented with tetracycline. From 10
transducts the plasmids were isolated and checked for insert
by restriction analysis. All contained insert with an
estimated average size of 17 kb. A total number of 2400
colonies was transferred to 96-well microtiter plates
containing Luria±Bertani and tetracycline. After overnight
growth, glycerol was added and the library was stored at
280 8C until use.
`Touch down' PCR on total DNA
All PCR amplifications were performed as described by
Innis and Gelfand [25]. The 50-mL reaction mixtures
contained PCR buffer (Roche), 200 mm of each dNTP,
20±30 pmol primer, 1±5 units Taq or Pwo polymerase and
10±100 ng template.
The following degenerated primers were designed on the
N-terminal amino-acid sequences of the purified enzymes:
HAPMO, PAMOACB1 (forward) 5 0-GAAACCATGGCN
GCNTTYAAYACNACNYTNCC-3 0 and PAMOACB2
(reverse) 5 0-GAAAACCATGGRTCRTCRTCRTARTCNA
RNGWNGG-3 0; esterase (4-hydroxyphenyl acetate hydro-
lase), PESACB1 (forward) 5 0-GAAACCATGGCNCTNG
AYGTNGARWCNGCNCARCTNCTNGG-30 and PESACB2
(reverse) 5 0-GAAAACCATGGYTCNGCNAGYTGNCCN
AGNAGYTG 3 0 (NcoI sites are underlined and the
substituted nucleotide in PAMOACB1 is shown in bold).
Touch-down PCR was performed on total DNA of
P. fluorescens ACB [26]. After initial denaturation for
5 min at 94 8C, the cycling program was as follows: 1 min
94 8C, 1 min 60 8C (2 8C decrease after every two cycles to
48 8C) and elongation at 72 8C for 2 min. In addition, 25
cycles were performed at a hybridization temperature of
48 8C and elongation for 1 min at 72 8C. The fragment
obtained using the PESACB1 and PAPMO2 primers was
ligated into the pCR2.1-TOPO vector and then transformed
into E. coli TOP10F 0 cells according to the recommenda-
tions of the manufacturer (Invitrogen). Plasmids containing
insert were purified from overnight cultures with the High
PureTM plasmid isolation kit (Roche).
Preparation of a digoxigenin-labelled probe
To prepare the probe to screen the genomic library, the
hapD gene in pCR2.1 was amplified with Taq polymerase
(Roche) using the primers PESACBf (5 0-GAAACCATG
GCTCTTGACGTCGAGACGGCACAGCTG-3 0) and
PESACBr (5 0-GAAAGGATCCTAAAAAGGGTTTCAGC
CAAGGCTTGAT-3 0) during 30 cycles of 1 min 94 8C,
1 min 60 8C and 1 min at 72 8C. The amplified fragment
was isolated from gel and labelled with digoxigenin (DIG)
by random-priming according to the method described by
the DIG system user's guide for filter hybridization
(Boehringer) yielding the DIG-labelled probe HAP2.
Screening of the genomic library
For screening, the constructed library was plated from the
frozen stock on Luria±Bertani plates supplemented with
12.5 mg´mL21 tetracycline and incubated overnight at
37 8C. Colonies were transferred to cellulose nitrate mem-
branes. The membranes were processed and subsequently
hybridized with the DIG-labelled HAP2 probe at 68 8C.
Two primers, designed on the nondegenerated part of the
hapD sequence were used to check E. coli clones which
gave a positive signal after blotting: PESACB3 (5 0-GAA
GCCGTTCCATTTCT-3 0) and PESACB4 (5 0-GCCAAGG
CTTGATCTGATC-3 0). Cycling parameters were as fol-
lows: 1 min at 94 8C, 1 min at 57 8C and 1 min at 72 8C.
As templates the pLAFR3 cosmids were isolated from the
positive clones.
Cloning, expression and purification of recombinant
HAPMO
The hapE gene was amplified with Pwo polymerase using
the total DNA of P. fluorescens ACB as template. There-
fore, two primers were designed: PAPMO1 (5 0-CACGG
CATATGAGCGCCTTCAATACC-3 0, NdeI site underlined)
and PAPMO2 (5 0-CACGGGGATCCTCAACCTAGTTGG
TAATCAGTCGG-3 0, BamHI site in italic type). Cycling
parameters were as follows: 30 cycles of 1 min at 94 8C,
1 min at 56 8C and 1 min at 72 8C. After amplification, the
gene was isolated from gel, digested with NdeI and BamHI
and ligated behind the T7 promoter of the NdeI/BamHI
digested expression vector pET-5a (Promega) yielding
pHAPE1.
E. coli BL21(DE3)pLysS was transformed with this
construct and grown in Luria±Bertani medium supple-
mented with 100 mg´mL21 ampicillin and 35 mg´mL21
chloramphenicol at 30 8C. When the D600 reached 0.8,
0.4 mm isopropyl thio-b-d-galactoside was added and the
cells were grown for another 12±14 h at 20 8C. Cells (6 g)
were harvested by centrifugation, resuspended in 50 mm
potassium phosphate, pH 7.0, containing 0.1 mm EDTA
and 0.1 mm dithiothreitol, and sonicated to prepare cell
extract. After ultracentrifugation for 60 min at 110 000 g,
the supernatant was applied onto a ceramic hydroxyapatite
column (2.5  12 cm), equilibrated with 50 mm potassium
phosphate, pH 7.0, and eluted with the same buffer.
Fractions containing HAPMO activity were pooled and
loaded onto a Q-Sepharose column (2.5  18 cm) equili-
brated with 50 mm potassium phosphate, pH 7.0. After
washing with starting buffer, the enzyme was eluted with a
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linear gradient of 0±1 m KCl in the same buffer. HAPMO
eluted at a concentration of 0.6 m KCl. Active fractions
were concentrated by ultrafiltration, dialysed in 50 mm
potassium phosphate, pH 7.0, and stored at 280 8C.
PCR amplification to create truncated HAPMO variants
Two primers were designed to amplify truncated hapE
genes. Primer PHAPMO3, 5 0-CACGGCATATGGCCAGC
GGCCGCGACTTCAAGGTGGTG-3 0 annealed just
upstream the part of the gene encoding the first Rossman
fold sequence motif. Val136 was mutated to a methionine to
create a NdeI site. Primer PHAPMO8, 5 0-CACGGCAT
ATGGCCGAAGAAGCCGTGACCGCC-3 0 was used to
create a mutant lacking the part encoding the first 114
amino acids. Due to the introduction of a NdeI site, Ile115
was replaced by a methionine (NdeI sites underlined, start
codon in bold, substituted codons in italic type). PCR with
Pwo polymerase, using either PHAPMO3 or PHAPMO8 in
combination with PAPMO2 as the reverse primer, under the
same conditions as described for hapE amplification,
yielded fragments which were cloned with NdeI/BamHI
in the pET5-a vector yielding pHAPE2 and pHAPE3,
respectively. Successful cloning was confirmed by plasmid
sequencing.
Site-directed mutagenesis
The Quickchange site-directed mutagenesis kit (Stratagene)
was used to introduce a point mutation into HAPMO
changing the glycine at position 490 into an alanine. Two
primers were used, Primer 1 (5 0-GTGTATGGCACGGC
GTTCCATGCCTCG-3 0) and primer 2 (5 0-CGAGGCATG
GAACGCCGTGCCATACAC-3 0). The mutagenic codon is
shown in italic. The PCR reaction, with pHAPE1 as
template, was performed under the conditions recom-
mended by the manufacturer. Successful mutagenesis was
confirmed by plasmid sequencing.
Steady-state kinetics
HAPMO activity was determined spectrophotometrically
by monitoring the decrease of NADPH at 370 nm
(:370  2.7 mm21´cm21). Reaction mixtures (1 mL) typi-
cally contained 50 mm potassium phosphate pH 8.0,
0.25 mm NADPH and 50±100 nm enzyme. The reaction
was started by the addition of 10 mL 0.1 m 4-hydroxy-
acetophenone in dimethylformamide. Specific activities
were corrected for endogenous NADPH oxidase activity.
One unit of HAPMO activity is defined as the amount of
protein that oxidizes 1 mmol´min21 NADPH. All kinetic
measurements were performed at 30 8C using air-saturated
buffers.
Steady-state kinetic parameters for acetophenone deriva-
tives were estimated using a concentration range of 2.0 mm
to 5.0 mm and a fixed concentration of 0.25 mm NADPH.
The K 0m and V 0max for NADPH were estimated using a
fixed concentration of 200 mm 4-hydroxyacetophenone and
NADPH concentration range of 30±300 mm.
Formation of hydrogen peroxide was measured indirectly
by adding a catalytic amount of catalase after completion of
a HAPMO-catalysed conversion. Oxygen consumption and
formation were monitored using an optical oxygen sensor
`Mops-1' (Prosense, Germany).
4-Hydroxyphenyl acetate hydrolase activity was deter-
mined spectrophotometrically by monitoring the production
of p±nitrophenol at 405 nm (:405  7745 m21´cm21, as
determined experimentally at pH 7.0). Reaction mixtures
contained 1±100 mg protein in 1 mL of a saturated solution
of p-nitrophenyl acetate in phosphate buffer (pH 7.0).
Isotope labelling experiment
For 18O incorporation experiments, 150 mL H182 O was
added to 327.5 mL 1.0 mm aromatic substrate in 50 mm
phosphate buffer pH 7.0. After addition of HAPMO
(2.5 mL, 200 mm) and NADPH (20 mL, 25 mm) the
samples were incubated for 10 min and subsequently
extracted with 1 mL diethylether. GC-MS analysis of the
ether extracts was performed on a Hewlett Packard HP
5890 series II gas chromatograph and a Hewlett Packard HP
5971 mass spectrometer equipped with an HP-5 column.
Samples (1 mL) were injected without derivatization, and
the temperature program was 1 min isothermal at 80 8C
followed by an increase to 150 8C at 10 8C´min21 and
finally 4 min at this temperature.
Analytical methods
Protein content was determined with Coomassie Brilliant
Blue using BSA as the standard. SDS/PAGE was carried
out on 12.5% slab gels. The Amersham Pharmacia Biotech
low molecular mass calibration kit containing phospho-
rylase b (94 kDa), BSA (67 kDa), ovalbumin (43 kDa),
carbonic anhydrase (30 kDa), soybean trypsin inhibitor
(20.1 kDa), and a-lactalbumin (14.4 kDa) served as a
reference. Proteins were stained with Coomassie Brilliant
Blue G250. The relative molecular mass of native HAPMO
was determined by FPLC gel filtration using a Superdex
200 HR 10/30 column (Pharmacia Biotech) running with
50 mm potassium phosphate buffer pH 7.0 containing
150 mm KCl. The column was calibrated with blue dextran
2000, thyroglobulin (669 kDa), ferritin (440 kDa), catalase
(232 kDa), aldolase (158 kDa), lipoamide dehydrogenase
(100 kDa), p-hydroxybenzoate hydroxylase (88 kDa),
BSA (67 kDa), ovalbumin (43 kDa), chymotrypsinogen A
(25 kDa), myoglobin (17.8 kDa) and cytochrome c
(12.3 kDa).
The flavin prosthetic group of HAPMO was isolated
and identified by reverse-phase HPLC according to the
procedure described for 4-hydroxybenzoate 1-hydroxylase
[27].
Absorption spectra were recorded at 25 8C on an Aminco
DW-2000 spectrophotometer or a PerkinElmer Lambda
Bio40 spectrophotometer. Flavin fluorescence emission
spectra were recorded on an SPF-500 spectrofluorimeter
essentially as described elsewhere [28].
DNA was cycle-sequenced with the Amersham Thermo
Sequenase cycle-sequencing kit with 7-deaza-dGTP and
Cy5 labelled fluorescent primers. Sequencing reaction
mixtures were run on the Pharmacia ALF-Express DNA
sequencer. The N-terminal amino-acid sequences of puri-
fied HAPMO and 4-hydroxyphenyl acetate hydrolase were
determined by automatic Edman degradation at Euro-
sequence BV (Groningen, the Netherlands). The blast
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program [29] at the National Center for Biotechnology
Information (www.ncbi.nlm.nih.gov/BLAST/) was used
to search for proteins showing sequence similarity.
Multiple sequence alignments were made with the
clustal w program at the European Bioinformatics
Institute (www.ebi.ac.uk/clustalw) [30].
R E S U LT S
Purification of HAPMO from P. fluorescens ACB
Purification of HAPMO by anion exchange and hydro-
phobic chromatography resulted in a homogeneous enzyme
preparation which is free of esterase activity. Table 1
summarizes a typical purification from 200 g 4-hydro-
xyacetophenone-grown P. fluorescens ACB cells. The
enzyme was purified 25-fold with an overall yield of nearly
50%. SDS/PAGE revealed the presence of a single
polypeptide chain, corresponding to an apparent molecular
mass of < 70 kDa. The purified enzyme elutes from an
analytical Superdex 200 gel filtration column in one
symmetrical peak with an apparent molecular mass of
140 ^ 5 kDa. This suggests that native HAPMO from
P. fluorescens ACB occurs as a homodimer in solution.
Spectral properties and identification of prosthetic
group
The optical spectrum of HAPMO shows maxima at 382 and
440 nm, indicative of a flavoprotein (Fig. 1A). The ratio of
the absorbance at 280 nm relative to that at 440 nm was
15.5. Unfolding of the enzyme revealed that the flavin
cofactor is noncovalently bound. Incubation for 10 min of
native HAPMO in the presence of 0.1% SDS leads to a final
spectrum which corresponds to the absorbance of free FAD
(Fig. 1A). The identity of the flavin prosthetic group was
confirmed by HPLC and fluorescence analysis. From the
absorbance difference between free and protein-bound
FAD, a value of 12.4 mm21´cm21 is estimated for the
molar absorption coefficient (:440) of HAPMO at pH 7.0.
Moreover, from the absorbance at 440 nm and protein
content, it is concluded that each HAPMO subunit contains
one molecule of FAD. The flavin fluorescence in HAPMO
is strongly quenched. Comparison with flavin standards
revealed that the relative fluorescence quantum yield of
protein-bound FAD is less than 1% of free FAD (pH 7.0).
Catalytic properties
HAPMO from P. fluorescens ACB catalyses the FAD-
dependent conversion of 4-hydroxyacetophenone to
4-hydroxyphenyl acetate with consumption of stoichio-
metric amounts of NADPH and molecular oxygen. Almost
zero activity was found with NADH. The pH and tem-
perature optima for enzyme catalysis are 7.5 and 30 8C,
respectively. The specific activity of the purified enzyme
is < 5.5 mmol NADPH oxidized´min21´mg21 under the
conditions of the standard assay (pH 8.0). Addition of free
FAD to the assay mixture did not stimulate HAPMO
activity, indicating that the flavin cofactor is tightly bound.
To asses whether the FAD cofactor is involved in catalysis
the enzyme was titrated with NADPH under anaerobic
conditions. It was found that the flavin is readily reduced by
NADPH (Fig. 1B). The full two-electron reduction of the
FAD cofactor, as evidenced by the absorption decrease in
the region 400±500 nm, indicates that all cofactor mol-
ecules participate in the reduction reaction. Upon restoring
aerobic conditions by flushing the enzyme solution with air,
the FAD cofactor is reoxidized within 5 min showing the
ability of molecular oxygen to reoxidize the flavin cofactor.
Oxygen consumption experiments performed in the absence
or presence of catalase confirmed that in the absence of
substrate the enzyme can act as an NADPH oxidase,
Fig. 1. Spectral properties of HAPMO from P. fluorescens ACB.
The absorption spectra of HAPMO were recorded in 50 mm potassium
phosphate buffer pH 7.0. (A) Absorption spectra of native (1) and
unfolded HAPMO (2) and of the G490A mutant (3). HAPMO was
unfolded by incubation of the enzyme in 0.1% SDS. (B) Spectral
properties of oxidized and reduced HAPMO (3.0 mm).Oxidized
HAPMO (1) was fully reduced by addition of 15 mm NADPH (2).
Upon restoring aerobic conditions, the flavin becomes fully reoxidized
(3).
Table 1. Purification of 4-hydroxyacetophenone monooxygenase













Cell extract 800 30210 6552 0.22 100
Q-Sepharose 35 2610 4959 1.90 76
Phenyl-Sepharose 25 569 3129 5.50 48
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forming hydrogen peroxide. Such an uncoupling reaction
has also been observed for other flavin-dependent mono-
oxygenases [6,31]. To determine the rate of the observed
oxidase activity, consumption of NADPH was monitored in
the absence of aromatic substrate revealing a low reactivity
(k 0cat  0.11´s21, K 0m(NADPH)  5.0 mm). Furthermore,
analysis of the amount of hydrogen peroxide produced
during conversion of 4-hydroxyacetophenone or aceto-
phenone showed that in the presence of these aromatic
substrates the uncoupling reaction does not occur as no
hydrogen peroxide could be detected.
Substrate specificity
HAPMO catalyses the conversion of a wide range of
acetophenone derivatives. The highest catalytic efficiency
is observed with compounds bearing an electron donating
substituent at the para position of the aromatic ring
(Table 2). The apparent kinetic parameters listed in
Table 2 indicate that the preference for these compounds
is related not only to the rate of substrate conversion but
also to substrate affinity. Table 2 also shows that the
enzyme is rather active with the substrate analogues
4-hydroxybenzaldehyde and 4-hydroxypropiophenone.
Cyclohexanone and cyclopentanone, which are substrates
for some known Baeyer±Villiger monooxygenases [17], are
not converted by HAPMO.
Isotope labelling experiments
To confirm the Baeyer±Villiger monooxygenation reaction
and the formation of ester product, the enzymatic conver-
sion was carried out with acetophenone and 4-hydroxy-
acetophenone as substrates in the presence of 30% (v/v)
H182 O. After extraction of the reaction mixture with
diethylether, samples were analysed by GC-MS. As a
product from acetophenone conversion, phenyl acetate was
identified giving a M1 of m/z 136 and a base peak of m/z
94. The fragmentation pattern of the phenyl acetate
spectrum was identical to that obtained after performing
the enzymatic reaction with acetophenone in nonlabeled
H2O. This excludes the possibility that the oxygen atom
inserted is derived from water and confirms the nature of
the enzymatic Baeyer±Villiger monooxygenation reaction.
Incubation with 4-hydroxyacetophenone showed only the
formation of nonlabeled hydroquinone. This observation is
attributed to the instability of the formed 4-hydroxyphenyl
acetate.
Cloning strategy
During growth of P. fluorescens ACB on minimal medium
with 4-hydroxyacetophenone as sole source of carbon and
energy, it was observed that production of HAPMO
coincided with an increase in esterase activity, causing
hydrolysis of the formed 4-hydroxyphenyl acetate (data not
shown). As both enzymes are metabolically coupled [13], it
was expected that the corresponding genes might be located
in one operon. Therefore, both enzymes were purified and
the N-terminal amino-acid sequences were determined. For
HAPMO, 20 residues were identified (Ser-Ala-Phe-Asn-
Thr-Thr-Leu-Pro-Ser-Leu-Asp-Tyr-Asp-Asp-Asp-Thr-Leu-
Arg-Glu-His) whereas for the esterase 21 residues (Thr-
Leu-Asp-Val-Glu-Ser-Ala-Gln-Leu-Leu-Gly-Gln-Leu-Ala-
Glu-Arg-Gly-Ala-Lys-Pro-Phe) were identified.
Four degenerated primers based on the N-terminal
amino-acid sequences were designed; one forward primer
and one reverse primer for each terminus. Touch-down PCR
on total DNA of P. fluorescens ACB with the four logical
primer combinations resulted in a fragment of 1035 bp,
designated HAP1, when the primers PESACB1 and
PAPMO2 were used. Taking the orientation of the primers
into account it could be concluded that the esterase gene
had been amplified. Analysis of the nucleotide sequence,
after cloning HAP1 in the pCR2.1 TOPO vector, revealed
an ORF of which the deduced amino-acid sequence showed
high similarity with those of various lipases and esterases.
Furthermore, the calculated molecular mass of < 33 kDa
and the N-terminal amino-acid residues confirmed that the
ORF encoded the esterase. Downstream of the esterase
gene, a partial ORF was identified that encodes a peptide
fully consistent with the determined N-terminal peptide
sequence of HAPMO. These findings prompted us to use
the esterase gene, designated hapD, as a probe to screen a
genomic library.
Table 2. Steady-state kinetic parameters of HAPMO. All experiments were performed at 30 8C in air-saturated 50 mm potassium phosphate
buffer pH 8.0. Apparent turnover rates (k 0cat) and apparent Michaelis constants (K 0m) were determined at fixed concentrations of either NADPH






k 0cat /K 0m
103 s21´m21
NADPH 64 ^ 14 9.3 ^ 0.7 145
4-Hydroxyacetophenone 39  9.0 10.1 ^ 1.1 259
4-Aminoacetophenone 3.0 ^ 1.0 12.3 ^ 0.7 4100
4-Methylacetophenone 161  36 6.3 ^ 0.5 39
4-Methoxyacetophenone 541  119 1.7 ^ 0.2 3.1
4-Fluoroacetophenone 1040 ^ 301 0.6 ^ 0.1 0.6
acetophenone 2270  873 4.5 ^ 1.2 2.0
4-Hydroxy-3-methylacetophenone 380  27 5.4 ^ 0.1 14
4-Hydroxypropiophenone 12  0.5 10.6 ^ 0.4 883
4-Hydroxybenzaldehyde 101  16 7.6 ^ 0.3 75
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Genomic library screening and sequence of the hapE
gene
A genomic library of P. fluorescens ACB was constructed
using the cosmid vector pLAFR3 as described under
Materials and methods. The hapD gene was amplified
from pCR2.1, DIG-labelled and used as a probe. Screening
of 1440 clones yielded two positive clones. PCR analysis
confirmed that the hapD sequence was present on both
plasmids and therefore the flanking regions of the esterase
Fig. 2. Multiple sequence alignment of HAPMO from P. fluorescens ACB with other Baeyer±Villiger monooxygenases. The N-terminal
truncated HAPMO sequence is aligned with cyclohexanone monooxygenase from Acinetobacter sp. NCIB 9871 (Acin, P12015) [41], steroid
monooxygenase from Rhodococcus rhodochrous (Rhod, BAA24454) [40] and two cyclohexanone monooxygenases from a Brevibacterium isolate
[42]. The regions indicative for FAD and NADPH binding are marked with asterisks and circles, respectively [34].
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gene were sequenced. Sequencing of a 14-kb fragment
revealed that the gene encoding HAPMO is the fifth ORF of
an operon encoding genes involved in the degradation of
4-hydroxyacetophenone (data not shown). We therefore
designated it hapE. The sequence has been deposited in the
Genbank. The hapE gene encodes a protein of 640 amino
acids with a deduced molecular mass of 71 884 Da, which
is in line with the subunit molecular mass determined for
the native enzyme.
Protein sequence comparison
Alignment with the known Baeyer±Villiger monooxygenases
showed that HAPMO possesses 33 and 27% sequence
identity with steroid monooxygenase from Rhodococcus
rhodochrous and cyclohexanone monooxygenase from
Acinetobacter sp. NCIB 9871, respectively. Sequence
identities with the two newly identified cyclohexanone
monooxygenases from a Brevibacterium isolate were 31%
for Bre1 and 26% for Bre2 (Fig. 2). Intriguingly,
HAPMO has an extension of <135 residues at the
N-terminus which is not found in the other Baeyer±Villiger
monooxygenase sequences. Furthermore, relatively high
degrees of sequence identity were found for ORFs from
P. fluorescens (38%), Streptomyces coelicolor (33%),
Mycobacterium tuberculosis (33%), and a Rhizobium sp.
(32%). This suggests that Baeyer±Villiger monooxy-
genases are widespread throughout the eubacteria. Lower
degrees of sequence identity (20±25%) were found with the
eukaryotic flavin-containing monooxygenases. The most
conserved regions, located at the N-terminal half of the
homologous sequences, contain two typical GXGXX(G/A)
Rossman fold fingerprints (Fig. 2). These two sequence
motifs are indicative of the presence of two bab dinucleo-
tide binding folds [32] binding the adenylate parts of the
FAD and NAD(P)H cofactors.
Expression and purification of recombinant HAPMO
For expression in E. coli, the hapE gene was placed under
control of a T7 promoter in the expression vector pET5-a.
When expression of HAPMO was induced in cells grown at
30 8C, part of the enzyme was produced as inclusion bodies
as evidenced by SDS/PAGE analysis of whole cells. By
lowering the temperature to 20 8C, formation of inclusion
bodies could be prevented while yielding reasonable
expression of soluble and active enzyme. Recombinant
HAPMO was purified from E. coli BL21(DE3)pLysS
harbouring pHAPE1 in a two-column procedure (Fig. 3).
From 1-L culture, 30 mg enzyme could be purified with a
yield of 70%. The A280 /A440 ratio of purified recombinant
HAPMO was 15.6 which is similar to the value found for
the enzyme isolated from P. fluorescens ACB. Moreover,
the hydrodynamic properties and catalytic features of the
recombinant enzyme are identical when compared to
HAPMO purified from the wild-type strain.
Truncation of HAPMO
Because the N-terminal region of HAPMO does not show
any similarity with known protein sequences it was
anticipated that this part of the protein might not be
essential for catalysis. To test this hypothesis, two mutant
constructs, pHAPE2 and pHAPE3, were created that lack
the coding region for the first 135 and 114 N-terminal
amino-acid residues, respectively. However, SDS/PAGE
analysis of cell extracts and whole cells transformed
with these constructs showed that there was no visible
expression of the truncated proteins at an induction
temperature of 20 8C. Raising the induction temperature
to 30 8C resulted in the formation of inclusion bodies.
Activity was no detected in the cell extracts at either
induction temperatures. Apparently, the N-terminal part of
HAPMO is of importance for the structural integrity of the
enzyme.
Properties of the G490A mutant
Recently, an ATG sequence motif was described to be
common for FAD and NAD(P)H binding proteins [33,34].
Since this sequence motif is also found in HAPMO (Fig. 2)
and its function is still unclear, we decided to mutate the
strictly conserved glycine 490 into an alanine. The mutant
was overexpressed and purified according to the protocol
for wild-type HAPMO. Gel filtration showed that the
mutant enzyme was purified as a dimer. The ratio of the
absorbance at 280 nm relative to that at 440 nm was 17.5,
indicating that the enzyme is saturated with FAD. However,
the shape of the flavin spectrum of the Gly490Ala mutant
differs significantly from that of the wild-type enzyme
(Fig. 1A). The oxidase activity of this mutant is signifi-
cantly higher than that of the wild-type enzyme
(k 0cat  0.4´s21) but the Michaelis constant for NADPH
is rather high (K 0m(NADPH)  700 mm). In contrast with the
wild-type enzyme, addition of 4-hydroxyacetophenone did
not stimulate the rate of NADPH oxidation. However,
GC-MS analysis revealed that the Gly490Ala mutant is still
able to catalyse the Baeyer±Villiger oxidation of the
aromatic substrate.
D I S C U S S I O N
This paper describes the purification, characterization and
cloning of HAPMO, a novel FAD-dependent Baeyer±Villiger
Fig. 3. SDS/PAGE of purification steps of recombinant 4-hydroxy-
acetophenone monooxygenase from E. coli BL21(DE3)pLysS. Lane
1 and 6, marker proteins; lane 2 and 3, cell extract at two
concentrations; lane 4, hydroxyapatite fraction; lane 5 and 7,
Q-Sepharose fraction at two concentrations.
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monooxygenase which is induced when P. fluorescens ACB
is grown on 4-hydroxyacetophenone. HAPMO catalyses the
first step in the degradation of 4-hydroxyacetophenone by
inserting an oxygen atom in between the aromatic ring and
the ketone side chain, yielding 4-hydroxyphenyl acetate. In
addition to the conversion of 4-hydroxyacetophenone,
HAPMO catalyses the oxygenation of a wide range of
other aromatic ketones to the corresponding esters; by this,
the enzyme is able to form a range of acylated phenols and
catechols. As acylcatechols are valuable synthons for the
fine chemical industry, HAPMO might develop as a useful
biocatalytic tool. Furthermore, HAPMO resembles a
recently isolated Baeyer±Villiger monooxygenase from
P. putida JD1, that displays a similar substrate specificity
and subunit molecular mass [16]. From this enzyme, only
the N-terminal amino-acid sequence and two internal
peptide sequences were determined which reveal a signifi-
cant (80%) sequence identity with HAPMO. This indicates
that Baeyer±Villiger monooxygenases acting on aromatic
compounds frequently occur in nature.
Several Baeyer±Villiger monooxygenases acting on
nonaromatic compounds have been identified in bacteria
and fungi. All of these enzymes were shown to contain a
flavin cofactor [35±39]. On the basis of the available
biochemical data, Baeyer±Villiger monooxygenases have
been divided into two subclasses [17]. Type I Baeyer±
Villiger monooxygenases contain FAD as cofactor, are
NADPH dependent and appear as monomers, homodimers
or homotetramers. In contrast, type II Baeyer±Villiger
monooxygenases contain FMN as cofactor, show NADH
dependency and consist of two different subunits organized
in a a2b conformation. So far, only two type I Baeyer±
Villiger monooxygenases have been cloned and
characterized. These are steroid monooxygenase from
Rhodococcus rhodochrous [40] and cyclohexanone mono-
oxygenases from Acinetobacter NCIB 9871 [41] and a
Brevibacterium isolate [42]. Within their N-termini, the
Rossman fold fingerprint motif GxGxxG is found, which is
thought to be involved in binding the ADP part of FAD
[43].
HAPMO from P. fluorescens ACB is strictly dependent
on NADPH and was found to be a homodimer with each
72-kDa subunit containing a noncovalently bound FAD.
This and the significant sequence homology with cyclo-
hexanone monooxygenase and steroid monooxygenase
clearly classifies HAPMO as a type I Baeyer±Villiger
monooxygenase. Besides the substrate specificity, there are
some striking structural features that distinguishes HAPMO
from the other type I Baeyer±Villiger monooxygenases.
First, due to an N-terminal extension of < 135 amino acids,
the HAPMO subunit is much larger than that of related
enzymes. As a consequence, the Rossman fold sequence
motif indicative of FAD binding is not localized within the
first 30 N-terminal amino-acid residues but is situated 148
residues from the N-terminus (Fig. 2). In cyclohexanone
monooxygenase, this fingerprint sequence starts at residue
12 and in steroid monooxygenase at residue 27. We
constructed truncated forms of HAPMO to explore the
functionality of the N-terminal extension. However, the
truncated HAPMO variants could not be expressed in a
soluble form, suggesting that the N-terminal domain of
HAPMO is important for the protein structural integrity.
Another unique feature of HAPMO concerns the absence of
a conserved aspartate near the N-terminal GxGxxG motif
proposed to be typical for type I Baeyer±Villiger mono-
oxygenases [17]. In the HAPMO sequence, a lysine
(Lys143) is present at this position (Fig. 2). From the
sequence analysis, we infer that this variance is probably
not unique for type I Baeyer±Villiger monooxygenases as a
similar feature is found in several of the HAPMO-related
open reading frames.
Several sequence motifs have been described for proteins
that bind both FAD and NADPH [5,34,44]. Besides the
classical Rossman fold sequence motif (GXGXXG/A), a
recently described ATG motif was shown to be indicative
for FAD and NAD(P) binding domains [34]. Furthermore,
two other short sequence motifs (GG and GD) have been
identified to be indicative for a Rossman fold domain
involved in FAD binding [34,44]. Upon alignment of the
type I Baeyer±Villiger monooxygenase sequences, most of
these sequence motifs could be identified displaying the
following arrangement: GXGXXG±GG±ATG±GXGXXG±
ATG (Fig. 2). In the HAPMO sequence, the only variations
within these sequence motifs involve the first ATG motif
(T!V) and the second GXGXXG motif (last G!A). The
variation in the first ATG motif has also been observed in
other flavoproteins whereas the alanine substitution in the
second GXGXXG motif suggests that it is part of the
NADPH binding domain [45,46]. This is in line with
mutagenesis studies on a sequence-related flavin-containing
monooxygenase from yeast where a conserved lysine near
the second Rossman fold fingerprint was shown to be
involved in binding of NADPH [47]. At this position a
strictly conserved arginine is found in the known type I
Baeyer±Villiger monooxygenase sequences (Arg339 in
HAPMO, see Fig. 2) which, in analogy, probably interacts
with the 2 0-phosphate moiety of NADPH. The second ATG
motif was recognized only recently. While Stehr et al. [33]
have proposed a functional role of this hydrophobic
sequence motif in substrate binding, analysis by Vallon
[34] suggested a primary role in NADPH binding. We have
assessed the functional role of this sequence motif by
replacing the strictly conserved glycine residue. Analysis of
the Gly490Ala mutant revealed a dramatic effect on
binding and oxidation of NADPH. The NADPH oxidase
activity was increased to some extent and the Michaelis
constant for NADPH increased by two orders of magnitude.
The mutant was still able to convert 4-hydroxyaceto-
phenone indicating that Gly490 is not crucial for substrate
recognition. Furthermore, spectral analysis indicated a
perturbation of the flavin microenvironment. These results
suggest that in HAPMO, the second ATG motif serves a
structural function which is of importance for NADPH
binding as proposed by Vallon [34].
The arrangement of sequence motifs in type I Baeyer±
Villiger monooxygenases resembles the sequence organ-
ization of the pyridine nucleotide-dependent disulfide
reductases [34] (e.g. glutathione reductase and lipoamide
dehydrogenase) and the b subunit of glutamate synthase
[46]. However, the Baeyer±Villiger monooxygenase
sequences are lacking the GD motif involved in binding
the FMN part of FAD [44]. The absence of this sequence
motif or any other significant sequence similarity in the
C-terminal half might well reflect the unique catalytic
properties of Baeyer±Villiger monooxygenases and mech-
anistically related N-hydroxylating enzymes [19,48].
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Expression of HAPMO, under the control of the T7
promotor [49], in E. coli BL21(DE3)pLysS resulted in
relatively large amounts of soluble and active enzyme. This
allows us to address in the near future the catalytic
mechanism and structure±function relationship of this
novel aromatic Baeyer±Villiger monooxygenase in further
detail.
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